Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy

Introduction: The differential diagnosis of splenomegaly is a complex process that encompasses a wide variety of diseases. Moreover, it is not always standardized and lacks a definitive consensus on which tests should be performed and in what order. Gaucher disease (GD) and acid sphingomyelinase def...

Full description

Saved in:
Bibliographic Details
Main Authors: Marta Morado Arias, Jesús Villarrubia Espinosa, Isidro Vitoria Miñana, Enrique Calderón Sandubete, Víctor Quintero, Miguel Ángel Torralba-Cabeza
Format: Article
Language:English
Published: MDPI AG 2025-03-01
Series:Diseases
Subjects:
Online Access:https://www.mdpi.com/2079-9721/13/4/102
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850183317448556544
author Marta Morado Arias
Jesús Villarrubia Espinosa
Isidro Vitoria Miñana
Enrique Calderón Sandubete
Víctor Quintero
Miguel Ángel Torralba-Cabeza
author_facet Marta Morado Arias
Jesús Villarrubia Espinosa
Isidro Vitoria Miñana
Enrique Calderón Sandubete
Víctor Quintero
Miguel Ángel Torralba-Cabeza
author_sort Marta Morado Arias
collection DOAJ
description Introduction: The differential diagnosis of splenomegaly is a complex process that encompasses a wide variety of diseases. Moreover, it is not always standardized and lacks a definitive consensus on which tests should be performed and in what order. Gaucher disease (GD) and acid sphingomyelinase deficiency (ASMD) are lysosomal diseases (LD) that present with splenomegaly, the diagnosis of which requires a high index of suspicion and specific biochemical and genetic techniques. The aim of the project for the education and diagnosis of Gaucher disease and acid sphingomyelinase deficiency (PREDIGA) was to conduct educational training alongside an observational, multicenter, ambispective, cross-sectional, single-cohort study among patients having an enlarged spleen or undergone splenectomy to further assess these subjects to exclude two lysosomal diseases, namely GD and ASMD. Methods: Using dried blood spot (DBS) testing, we identified patients with abnormally low values of the enzymes glucocerebrosidase and acid sphingomyelinase, who then underwent sequencing of the GBA1 and SPMD1 genes, respectively. The study involved 34 hospitals and 52 medical specialists. Results: We identified 220 patients (208 adults and 12 children under 18 years) with cryptogenic splenomegaly or who had undergone splenectomy (12 patients) without having reached a diagnosis. The median age was 11 years (interquartile range [IQR] 3–16) in the pediatric population and 51 years (IQR 38–65) in the adult population. Lower-than-normal enzyme values were detected in 19 DBSs, confirming eight positive cases, which corresponded to six patients with GD and two with ASMD. The rest of the DBSs with low enzyme activity were not genetically confirmed (58%). We determined that lysosomal diseases accounted for 3.6% of cryptogenic splenomegaly/splenectomy cases in our setting: 2.7% were GD and 0.9% ASMD, in a ratio of 1 ASMD patient to every 3 GD patients. Lyso-GL1 values in patients with GD were elevated in all but one individual, corresponding to a child diagnosed at 4 months old. The variants detected in the GBA1 gene were consistent with the most frequent variants found in Spain. Discussion/Conclusion: The development and implementation of this protocol for the education and diagnosis of cryptogenic splenomegaly/splenectomy, even in asymptomatic patients, constitutes a comprehensive, simple, rapid, and effective screening method for the diagnosis of GD and ASMD.
format Article
id doaj-art-dffd20f817364732929307cd399c0bb5
institution OA Journals
issn 2079-9721
language English
publishDate 2025-03-01
publisher MDPI AG
record_format Article
series Diseases
spelling doaj-art-dffd20f817364732929307cd399c0bb52025-08-20T02:17:24ZengMDPI AGDiseases2079-97212025-03-0113410210.3390/diseases13040102Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and SplenectomyMarta Morado Arias0Jesús Villarrubia Espinosa1Isidro Vitoria Miñana2Enrique Calderón Sandubete3Víctor Quintero4Miguel Ángel Torralba-Cabeza5Department of Hematology and Hemotherapy, Hospital Universitario La Paz, 28046 Madrid, SpainDepartment of Hematology and Hemotherapy, Hospital Universitario Ramón y Cajal, 28034 Madrid, SpainNutrition and Metabolic Disease Unit, Hospital Universitario La Fe, 46026 Valencia, SpainDepartment of Internal Medicine and Biomedicine Institute, Hospital Universitario Virgen del Rocío, 41013 Seville, SpainDepartment of Pediatric Hematology-Oncology, Hospital Universitario La Paz, 28046 Madrid, SpainDepartment of Internal Medicine, Hospital Universitario Lozano Blesa, 50009 Zaragoza, SpainIntroduction: The differential diagnosis of splenomegaly is a complex process that encompasses a wide variety of diseases. Moreover, it is not always standardized and lacks a definitive consensus on which tests should be performed and in what order. Gaucher disease (GD) and acid sphingomyelinase deficiency (ASMD) are lysosomal diseases (LD) that present with splenomegaly, the diagnosis of which requires a high index of suspicion and specific biochemical and genetic techniques. The aim of the project for the education and diagnosis of Gaucher disease and acid sphingomyelinase deficiency (PREDIGA) was to conduct educational training alongside an observational, multicenter, ambispective, cross-sectional, single-cohort study among patients having an enlarged spleen or undergone splenectomy to further assess these subjects to exclude two lysosomal diseases, namely GD and ASMD. Methods: Using dried blood spot (DBS) testing, we identified patients with abnormally low values of the enzymes glucocerebrosidase and acid sphingomyelinase, who then underwent sequencing of the GBA1 and SPMD1 genes, respectively. The study involved 34 hospitals and 52 medical specialists. Results: We identified 220 patients (208 adults and 12 children under 18 years) with cryptogenic splenomegaly or who had undergone splenectomy (12 patients) without having reached a diagnosis. The median age was 11 years (interquartile range [IQR] 3–16) in the pediatric population and 51 years (IQR 38–65) in the adult population. Lower-than-normal enzyme values were detected in 19 DBSs, confirming eight positive cases, which corresponded to six patients with GD and two with ASMD. The rest of the DBSs with low enzyme activity were not genetically confirmed (58%). We determined that lysosomal diseases accounted for 3.6% of cryptogenic splenomegaly/splenectomy cases in our setting: 2.7% were GD and 0.9% ASMD, in a ratio of 1 ASMD patient to every 3 GD patients. Lyso-GL1 values in patients with GD were elevated in all but one individual, corresponding to a child diagnosed at 4 months old. The variants detected in the GBA1 gene were consistent with the most frequent variants found in Spain. Discussion/Conclusion: The development and implementation of this protocol for the education and diagnosis of cryptogenic splenomegaly/splenectomy, even in asymptomatic patients, constitutes a comprehensive, simple, rapid, and effective screening method for the diagnosis of GD and ASMD.https://www.mdpi.com/2079-9721/13/4/102GaucherASMDsplenomegalysplenectomyDBS
spellingShingle Marta Morado Arias
Jesús Villarrubia Espinosa
Isidro Vitoria Miñana
Enrique Calderón Sandubete
Víctor Quintero
Miguel Ángel Torralba-Cabeza
Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
Diseases
Gaucher
ASMD
splenomegaly
splenectomy
DBS
title Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
title_full Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
title_fullStr Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
title_full_unstemmed Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
title_short Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy
title_sort study of adult and pediatric spanish patients with cryptogenic splenomegaly and splenectomy
topic Gaucher
ASMD
splenomegaly
splenectomy
DBS
url https://www.mdpi.com/2079-9721/13/4/102
work_keys_str_mv AT martamoradoarias studyofadultandpediatricspanishpatientswithcryptogenicsplenomegalyandsplenectomy
AT jesusvillarrubiaespinosa studyofadultandpediatricspanishpatientswithcryptogenicsplenomegalyandsplenectomy
AT isidrovitoriaminana studyofadultandpediatricspanishpatientswithcryptogenicsplenomegalyandsplenectomy
AT enriquecalderonsandubete studyofadultandpediatricspanishpatientswithcryptogenicsplenomegalyandsplenectomy
AT victorquintero studyofadultandpediatricspanishpatientswithcryptogenicsplenomegalyandsplenectomy
AT miguelangeltorralbacabeza studyofadultandpediatricspanishpatientswithcryptogenicsplenomegalyandsplenectomy